INO
Price:
$1.79
Market Cap:
$64.62M
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, pen...[Read more]
Industry
Biotechnology
IPO Date
1998-12-08
Stock Exchange
NASDAQ
Ticker
INO
According to Inovio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -26438.24%. This represents a change of 208.26% compared to the average of -8576.72% of the last 4 quarters.
The mean historical ROE of Inovio Pharmaceuticals, Inc. over the last ten years is -415.94%. The current -26438.24% ROE has changed 6.26% with respect to the historical average. Over the past ten years (40 quarters), INO's ROE was at its highest in in the March 2023 quarter at 1.48%. The ROE was at its lowest in in the September 2024 quarter at -34219.98%.
Average
-415.94%
Median
-69.18%
Minimum
-3509.41%
Maximum
-16.61%
Discovering the peaks and valleys of Inovio Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.05%
Maximum Annual ROE = -16.61%
Minimum Annual Increase = -98.67%
Minimum Annual ROE = -3509.41%
Year | ROE | Change |
---|---|---|
2023 | -115.14% | -11.00% |
2022 | -129.37% | 69.31% |
2021 | -76.41% | 63.82% |
2020 | -46.64% | -98.67% |
2019 | -3509.41% | 3.05% |
2018 | -111.54% | 80.06% |
2017 | -61.95% | 3.56% |
2016 | -59.81% | 260.04% |
2015 | -16.61% | -48.84% |
2014 | -32.48% | -74.20% |
The current ROE of Inovio Pharmaceuticals, Inc. (INO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-106.97%
5-year avg
-775.39%
10-year avg
-415.94%
Inovio Pharmaceuticals, Inc.’s ROE is less than Novavax, Inc. (0%), less than Vaxart, Inc. (44.82%), less than Enveric Biosciences, Inc. (-110.46%), less than CohBar, Inc. (-201.01%), less than Ocean Biomedical, Inc. (-58.44%), less than Hepion Pharmaceuticals, Inc. (75.64%), greater than Elevation Oncology, Inc. (-505.74%), less than AVROBIO, Inc. (-59.73%), less than null (29.68%),
Company | ROE | Market cap |
---|---|---|
0% | $1.38B | |
44.82% | $136.76M | |
-110.46% | $3.15M | |
-201.01% | $1.57M | |
-58.44% | $22.29M | |
75.64% | $3.48M | |
-505.74% | $33.90M | |
-59.73% | $5.24M | |
29.68% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inovio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Inovio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Inovio Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Inovio Pharmaceuticals, Inc. (INO)?
What is the highest ROE for Inovio Pharmaceuticals, Inc. (INO)?
What is the 3-year average ROE for Inovio Pharmaceuticals, Inc. (INO)?
What is the 5-year average ROE for Inovio Pharmaceuticals, Inc. (INO)?
How does the current ROE for Inovio Pharmaceuticals, Inc. (INO) compare to its historical average?